Toronto The Daily News – CrackedPudding.com

Top Menu

  • Login
  • Archives
  • Les Actualités
  • ESPAÑOL
  • Advertising
  • Contact Us

Main Menu

  • Home
  • Business
  • Entertainment
  • Food & Drink
  • Headline
  • Health
  • Editorials
  • Buzz
  • Lifestyle
  • Sports
  • Adults Only
  • Dating
Sign in / Join

Login

Welcome! Login in to your account
Lost your password?

Lost Password

Back to login
  • Login
  • Archives
  • Les Actualités
  • ESPAÑOL
  • Advertising
  • Contact Us

logo

Header Banner

Toronto The Daily News – CrackedPudding.com

  • Home
  • Business
  • Entertainment
  • Food & Drink
  • Headline
  • Health
  • Editorials
  • Buzz
  • Lifestyle
  • Sports
  • Adults Only
  • Dating
  • Interesting Museums to Visit Around Arlington, VA

  • The Best Small Towns to Check Out in Western Canada

  • 56 reports of ‘adverse events’ following COVID-19 vaccinations in B.C.

  • Adverse Events Reported From COVID-19 Vaccine Trials: A Systematic Review

  • Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study

Headline news
Home›Headline news›Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis

Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis

By admin
September 26, 2021
386
0
Share:

EMA’s safety committee (PRAC) has concluded that myocarditis and pericarditis can occur in very rare cases following vaccination with the COVID-19 vaccines Comirnaty and Spikevax (previously COVID-19 Vaccine Moderna).

The Committee is therefore recommending listing myocarditis and pericarditis as new side effects in the product information for these vaccines, together with a warning to raise awareness among healthcare professionals and people taking these vaccines.

Myocarditis and pericarditis are inflammatory conditions of the heart. Symptoms can vary but often include breathlessness, a forceful heartbeat that may be irregular (palpitations), and chest pain.

In reaching its conclusion, the Committee took into consideration all currently available evidence.

This included an in-depth review of 145 cases of myocarditis in the European Economic Area (EEA) among people who received Comirnaty and 19 cases among people who received Spikevax. PRAC also reviewed reports of 138 cases of pericarditis following the use of Comirnaty and 19 cases following the use of Spikevax. As of 31 May 2021, around 177 million doses of Comirnaty and 20 million doses of Spikevax had been given in the EEA.

In addition the PRAC also looked into cases received worldwide.

The Committee concluded that the cases primarily occurred within 14 days after vaccination, more often after the second dose and in younger adult men. In five cases that occurred in the EEA, people died. They were either of advanced age or had concomitant diseases. Available data suggest that the course of myocarditis and pericarditis following vaccination is similar to the typical course of these conditions, usually improving with rest or treatment.

Healthcare professionals should be alert to the signs and symptoms of myocarditis and pericarditis. They should tell people receiving these vaccines to seek immediate medical attention if symptoms indicative of myocarditis or pericarditis occur. These include breathlessness, a forceful heartbeat that may be irregular and chest pain.

Healthcare professionals should consult applicable guidance and/or consult specialists (e.g. cardiologists) to diagnose and treat these conditions.

At this point in time, no causal relationship with myocarditis or pericarditis could be established with two other COVID-19 vaccines authorised in the EEA, COVID-19 Vaccine Janssen and Vaxzevria1, and the Committee has requested additional data from the companies marketing these vaccines.

EMA confirms that the benefits of all authorised COVID-19 vaccines continue to outweigh their risks, given the risk of COVID-19 illness and related complications and as scientific evidence shows that they reduce deaths and hospitalisations due to COVID-19.

As for all vaccines, EMA will continue to monitor the vaccines’ safety and effectiveness and provide the public with the latest information, particularly as more adolescents and young adults are vaccinated and more second doses are given. The agency will take necessary action if any new safety issues are identified.

Information for the general public

  • Very rare cases of myocarditis and pericarditis (inflammatory conditions of the heart) have occurred in people who received Comirnaty and Spikevax (formerly COVID-19 Vaccine Moderna).
  • The chance of these conditions occurring is very low, but you should be aware of the symptoms so that you can get prompt medical treatment to help recovery and avoid complications.
  • You must seek medical attention immediately if you have the following symptoms after vaccination:
    • breathlessness
    • a forceful heartbeat that may be irregular
    • chest pain
  • Speak to your healthcare professional or contact your relevant national health authority if you have any questions about the rollout of the vaccines in your country.

Information for healthcare professionals

Following a review of very rare cases of myocarditis and pericarditis in people who received Comirnaty and Spikevax (formerly COVID-19 Vaccine Moderna), healthcare professionals should:

  • be alert to the signs and symptoms of myocarditis and pericarditis in people who have had these vaccines;
  • tell people receiving the vaccine that they must seek immediate medical attention if they have the following symptoms suggestive of myocarditis and pericarditis after vaccination: (acute and persisting) chest pain, palpitations or shortness of breath. People with myocarditis or pericarditis may require specialist treatment;
  • consult applicable guidance and/or consult specialists (e.g. cardiologists) to diagnose and treat these conditions. 

The product information will be updated to include myocarditis and pericarditis as side effects with unknown frequency.

A direct healthcare professional communication (DHPC) will be sent in due course to healthcare professionals prescribing, dispensing or administering the medicine. The DHPC will also be published on a dedicated page.

More about the medicine

Comirnaty and Spikevax (COVID-19 Vaccine Moderna) contain a molecule called mRNA which has instructions for making the spike protein. This is a protein on the surface of the SARS-CoV-2 virus which the virus needs to enter the body’s cells.

When a person is given one of these vaccines, some of their cells will read the mRNA instructions and temporarily produce the spike protein. The person’s immune system will then recognise this protein as foreign and produce antibodies and activate T cells (white blood cells) to attack it.

If, later on, the person comes into contact with SARS-CoV-2 virus, their immune system will recognise it and be ready to defend the body against it.

Post Views: 404
Previous Article

Are vaccines driving the emergence of “escape ...

Next Article

Alberta man says AstraZeneca shot led to ...

0
Shares
  • 0
  • +
  • 0
  • 0
  • 0
  • 0

Related articles More from author

  • Headline news

    Company offering employees $300 for pet adoption

    August 12, 2020
    By admin
  • Headline news

    Toronto ranked 7th most liveable city in the world

    August 21, 2018
    By admin
  • Headline news

    Don’t mix households on May long weekend, warns Toronto’s public health chief, pointing to past COVID-19 case spikes

    May 16, 2021
    By admin
  • Headline news

    Freddie Achom on Blockchain

    July 11, 2018
    By admin
  • Headline news

    ‘I want it to be disgustingly Canadian’: New video game will let you roam Toronto as a racc

    May 16, 2021
    By admin
  • Headline news

    A world-renowned immersive outdoor theatre experience is coming to Toronto

    May 23, 2021
    By admin

Popupar Articles

  • Week
  • Month

Week

  • Lottery Winner Collects R... Winning the lottery can sometimes be both a blessing an... 7 views
  • 9 best sex toys for coupl... Looking to make things more exciting in the bedroom... 5 views
  • BOMBSHELL: Google tracks... (Natural News) By now, most people realize that Google... 5 views
  • Alberta man says AstraZen... An Alberta man says he experienced a serious adverse e... 5 views
  • Toronto Pearson Airport s... International travellers arriving at Toronto Pearson I... 4 views
  • Nasa asteroid CONSPIRACY:... The distant 500 meter-wide space rock was discovered by... 4 views
  • Vegas Gambling Tips – Rea... You should probably not play at those slots at the air... 3 views
  • IGT: Betting on positive... For two and a half years the sports betting spotlight... 3 views
  • M’sian Shows up For First... Admittedly, everyone feels nervous on the first day at... 2 views
  • Beagle Adopts Baby Possum... A beagle who lost her litter of puppies has found renew... 2 views

Month

  • Alberta man says AstraZen... An Alberta man says he experienced a serious adverse e...
  • Toronto Pearson Airport s... International travellers arriving at Toronto Pearson I...
  • Lottery Winner Collects R... Winning the lottery can sometimes be both a blessing an...
  • Nasa asteroid CONSPIRACY:... The distant 500 meter-wide space rock was discovered by...
  • BOMBSHELL: Google tracks... (Natural News) By now, most people realize that Google...
  • Los latinoamericanos expe... La sociedad arcaica a la que los abuelos estaban acostu...
  • Self-Control Tips for Cas... Every successful casino gambler shares one fundamental...
  • 9 best sex toys for coupl... Looking to make things more exciting in the bedroom...
  • Why Is India Not on Googl... Google Play recently updated its policies on gambling...
  • A Toronto family bought a... Who: James Colaço, 43, management consultant at Deloit...



Recent Articles

  • Interesting Museums to Visit Around Arlington, VA
  • The Best Small Towns to Check Out in Western Canada
  • 56 reports of ‘adverse events’ following COVID-19 vaccinations in B.C.
  • Adverse Events Reported From COVID-19 Vaccine Trials: A Systematic Review
  • Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study
  • Alberta man says AstraZeneca shot led to serious health issue, wants federal compensation
  • Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis
  • Are vaccines driving the emergence of “escape mutant” variants of COVID-19?
  • All of the Evidence Is In: The Covid Vaccine Is a Failure
  • Judge denies terminated firefighters’ request to be reinstated

Most Viewed Articles

No Posts found

Visitors

  • Home
  • Business
  • Entertainment
  • Food & Drink
  • Headline
  • Health
  • Editorials
  • Buzz
  • Lifestyle
  • Sports
  • Adults Only
  • Dating